on avastin

Genentech's Trastuzumab-Dm1 Shows Great Promise in Treating Breast Cancer

"Overall, patients given Avastin in combination with IFL survived about five months longer and the average time before tumors started regrowing or new tumors appeared was four months longer than patients receiving IFL alone."

www.fda.gov/bbs/topics...

don't know where you got 2 months in colorectal. i think you maybe thinking of lung cancer:
"The median overall survival time for patients in the Avastin plus carboplatin and paclitaxel arm was 12.3 months versus 10.3 months for patients receiving only carboplatin and paclitaxel. "

www.fda.gov/bbs/topics...

and on cost, i think you're using the cost for lung cancer (and maybe breast too) but i think the cost for colorectal is 40k/yr.

On Jan 07 01:04 AM carey_jim wrote:

> I have to disagree with the previous comment. Your article was not
> clear to me.
>
> After plodding through the statistics (and admittedly giving up in
> frustration) from what I gather, your article confirms what is already
> clear and it is that the American pharmaceutical industry is completely
> bankrupt and even immoral in its search for a cure for cancer.<br/>
>
> Avastin, the other 'blockbuster' drug from Genentech, costs about
> $100,000 only to prolong the lives of advanced colon cancer patients
> by about two months.
>
> Cancer cure rates have remained almost flat for over twenty years.
>
>
> The profit motive doesn't seem to work well in science.
>
> Einstein wasn't interested in physics for the money.
>
> If Einstein had profited from his discoveries, he and his descendants
> would have become the richest people in the world (and possibly controlled
> the entire world.)
>
> My guess is that the drug discovery model will change in the near
> future and that pharmaceutical companies will fall on, at least compared
> with the past, hard times.
>
> Just a hunch, of course.

Genentech Q3 2008 Earnings Call Transcript

"We also believe it will allow us to defend this space from future competitors, including [panitumamab]."
should read:
"We also believe it will allow us to defend this space from future competitors, including ofatumumab."

What Price Might Roche Pay for DNA?

if roche can pay "any price" why offer 89$/sh? y not less, say 9$/sh?